Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 227

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 227
---

Trial by Jury

The Merger Agreement
provides that any action based upon, arising out of or related to the Merger Agreement or the transactions contemplated thereby may be
brought in federal and state courts located in the State of Delaware, and each of the parties irrevocably submits to the exclusive jurisdiction
of each such court in any such action, waives any objection it may now or hereafter have to personal jurisdiction,

venue or to convenience of forum, agrees
that all claims in respect of the action shall be heard and determined only in any such court, and agrees not to bring any action arising
out of or relating to the Merger Agreement or the transactions contemplated thereby in any other court. Nothing herein contained shall
be deemed

to affect the right of any party to
serve process in any manner permitted by law or to commence legal proceedings or otherwise proceed against any other Party in any other
jurisdiction, in each case, to enforce judgments obtained in any action properly brought. Each of the parties irrevocably waives any and
all right to trial by jury in any action based upon, arising out of or related to the Merger Agreement or the Mergers contemplated thereby.

Summary of the Ancillary Agreements

This section
describes certain additional agreements entered into or to be entered into pursuant to the Merger Agreement, but does not purport to describe
all of the terms thereof. The following summary is qualified in its entirety by reference to the complete text of each of the agreements.
The Sponsor Support Agreement, the Longevity Support Agreement, the form of Lock-Up Agreement and the form of A&R Registration Rights
Agreement and the form of Lock-Up Agreement are attached hereto as Annex C, Annex D, Annex E and Annex F respectively. You are urged to
read such agreements in their entirety prior to voting on the proposals presented at the Special Meeting.

Longevity Support Agreement

On September
16, 2024, in connection with the execution of the Merger Agreement, the sole stockholder of Longevity (the “Voting Stockholder”)
has entered into a Voting and Support Agreement (the “Longevity Support Agreement”), pursuant to which the Voting Stockholder
has agreed to, among other things, (i) vote in favor of the Merger Agreement and the transactions contemplated thereby and (ii) be bound
by certain other covenants and agreements related to the Transactions. The Voting Stockholder holds sufficient shares of Longevity to
cause the approval of the